Download PDF
Thromb Haemost 1997; 78(01): 527-531
DOI: 10.1055/s-0038-1657582
Hyperhomocysteinemia and thrombosis
Schattauer GmbH Stuttgart

Hyperhomocysteinemia and Thrombosis: Acquired Conditions

Jacob Selhub
1   Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA
,
Armando D'Angelo
2   Coagulation Service, Scientific Institute H.S. Raffaele, Milano, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1991; 55: 131-138
    PubMedGoogle Scholar
  • 2 Christensen B, Refsum H, Vintermyr O, Ueland PM. Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of nontransformed, transformed, proliferating, and quiescent cells in culture. J Cell Biol 1991; 146: 52-62
    PubMedGoogle Scholar
  • 3 McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111
    PubMedGoogle Scholar
  • 4 Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-1082
    CrossrefPubMedGoogle Scholar
  • 5 Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RBJ. (ed) Atherosclerotic Cardiovascular Disease Hemostasis, and Endothelial Function. New York: Marcel Dekker; 1992. pp 183-236
    Google Scholar
  • 6 Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057
    CrossrefPubMedGoogle Scholar
  • 7 Hirsh J, Prins MH, Samama M. Approach to the thrombophilic patient. in Colman RW, Hirsh J, Marder VJ, Salzman E. (eds) Hemostasis and Thrombosis: Basic and Clinical Practice. Philadelphia: Lippincott Company; 1994. p 1543
    Google Scholar
  • 8 Brattstrom L, Tengbom L, Lagerstedt C, Israelsson B, Hultberg B. Plasma homocysteine in venous thromboembolism. Haemostasis 1991; 21: 51-57
    PubMedGoogle Scholar
  • 9 Amundsen T, Ueland PM, Waage A. Plasma homocysteine levels in patients with deep venous thrombosis. Arterioscler Thromb Vase Biol 1995; 15: 1321-1323
    CrossrefPubMedGoogle Scholar
  • 10 Bienvenue T, Ankri A, Chadefauz B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis; relation to coagulation and fibrinolytic parameters. Thromb Res 1993; 70: 123-129
    CrossrefPubMedGoogle Scholar
  • 11 Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arterioscler Thromb 1994; 14: 1080-1083
    CrossrefPubMedGoogle Scholar
  • 12 Fermo I, Vi gano, D’Angelo S, Paroni R, Mazzola G, Calori G, D’Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med 1995; 123: 747-753
    CrossrefPubMedGoogle Scholar
  • 13 den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinemia a risk factor for recurrent thrombosis?. Lancet 1995; 345: 882-885
    CrossrefPubMedGoogle Scholar
  • 14 den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Hypeihomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med 1996; 334: 759-762
    CrossrefPubMedGoogle Scholar
  • 15 Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 335: 974-975 (letter)
    CrossrefPubMedGoogle Scholar
  • 16 Simloni P, Prandoni P, Burilina A, Tormene D, Sardella C, Ferrari V, Beneditti L, Girolami A. Hyperhomocysteinemia and deep-vein thrombosis. A case control study. Thromb Haemos 1996; 76: 883
    PubMedGoogle Scholar
  • 17 Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteoine as a risk factor for atherothrombotic events in systemic lupus erythmatosus. Lancet 1996; 348: 1120
    CrossrefPubMedGoogle Scholar
  • 18 Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligsohn U. Coexistence of hereditary homocystinuria and factor V Leiden — effect on thrombosis. N Engl J Med 1996; 334: 763-768
    CrossrefPubMedGoogle Scholar
  • 19 Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, Factor V Leiden, and risks of future venous thrombosis. Circulation. in press
    Google Scholar
  • 20 D’Angelo A, Fermo IVigano, D’Angelo S. Coexistence of hereditary homocystinuria and factor V Leiden — effect on thrombosis. N Engl J Med 1996; 335: 288 (letter)
    PubMedGoogle Scholar
  • 21 Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutrition 1996; 04 (Suppl) 1285S-1289S
    PubMedGoogle Scholar
  • 22 Upchurch Jr GR, Welch BH, Loscalzo J. Homocysteine, EDRF, and endothelial function. J Nutrition 1996; 126 (4 Suppl) 1290S-1294S
    PubMedGoogle Scholar
  • 23 Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71: 337-359
    CrossrefPubMedGoogle Scholar
  • 24 Mayer EL, Jacobsen DE, Robinson K. Homocysteine and coronary atherosclerosis. J Amer Coll Cardiol 1996; 27: 517-527
    CrossrefPubMedGoogle Scholar